These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 7958475)
41. Detection of peste des petits ruminants virus antigen using immunofiltration and antigen-competition ELISA methods. Raj GD; Rajanathan TM; Kumar CS; Ramathilagam G; Hiremath G; Shaila MS Vet Microbiol; 2008 Jun; 129(3-4):246-51. PubMed ID: 18182256 [TBL] [Abstract][Full Text] [Related]
42. Immunisation of cattle with a recombinant togavirus-vaccinia virus strain. Franke CA; Berry ES; Smith AW; Hruby DE Res Vet Sci; 1985 Jul; 39(1):113-5. PubMed ID: 3862196 [TBL] [Abstract][Full Text] [Related]
43. Inexpensive vaccines and rapid diagnostic kits tailor-made for the global eradication of rinderpest, and technology transfer to Africa and Asia. Yilma T; Aziz F; Ahmad S; Jones L; Ngotho R; Wamwayi H; Beyene B; Yesus M; Egziabher B; Diop M; Sarr J; Verardi P Dev Biol (Basel); 2003; 114():99-111. PubMed ID: 14677681 [TBL] [Abstract][Full Text] [Related]
44. Improved protection against simian immunodeficiency virus mucosal challenge in macaques primed with a DNA vaccine and boosted with the recombinant modified vaccinia virus Ankara and recombinant Semliki Forest virus. Martinon F; Brochard P; Ripaux M; Delache B; Aurégan G; Vaslin B; Le Grand R Vaccine; 2008 Jan; 26(4):532-45. PubMed ID: 18093703 [TBL] [Abstract][Full Text] [Related]
45. IL-12 delivery from recombinant vaccinia virus attenuates the vector and enhances the cellular immune response against HIV-1 Env in a dose-dependent manner. Gherardi MM; Ramirez JC; Rodríguez D; Rodríguez JR; Sano G; Zavala F; Esteban M J Immunol; 1999 Jun; 162(11):6724-33. PubMed ID: 10352291 [TBL] [Abstract][Full Text] [Related]
46. Research collaborations on rinderpest. Konnerup N J Am Vet Med Assoc; 2000 Jan; 216(2):176. PubMed ID: 10649747 [No Abstract] [Full Text] [Related]
47. Isolation of peste des petits ruminants from goats in Saudi Arabia. Abu Elzein EM; Hassanien MM; Al-Afaleq AI; Abd Elhadi MA; Housawi FM Vet Rec; 1990 Sep; 127(12):309-10. PubMed ID: 2238415 [No Abstract] [Full Text] [Related]
48. [Evaluation of vaccinal protection against rinderpest in Cameroon. III. General evaluation]. Ngangnou A; Zoyem N; Hamet M; Abdoulkadiri S Rev Elev Med Vet Pays Trop; 1996; 49(1):18-22. PubMed ID: 8881414 [TBL] [Abstract][Full Text] [Related]
49. Economic analysis of the development and usage of thermoresistant rinderpest vaccine. Stryker JD; Sollod AE; Stem E; Nababa A; van den Ende M Acta Vet Scand Suppl; 1988; 84():398-401. PubMed ID: 3232645 [No Abstract] [Full Text] [Related]
50. Development of heat-stable recombinant rinderpest vaccine. Tsukiyama K; Yoshikawa Y; Kamata H; Imaoka K; Asano K; Funahashi S; Maruyama T; Shida H; Sugimoto M; Yamanouchi K Arch Virol; 1989; 107(3-4):225-35. PubMed ID: 2818208 [TBL] [Abstract][Full Text] [Related]
51. Role of interferon in protection of rabbits against rinderpest virus. Fujisaki Y; Ishii S; Watanabe M Natl Inst Anim Health Q (Tokyo); 1968; 8(3):122-31. PubMed ID: 5712545 [No Abstract] [Full Text] [Related]
52. Protection of cattle against rinderpest and lumpy skin disease with a recombinant capripoxvirus expressing the fusion protein gene of rinderpest virus. Romero CH; Barrett T; Kitching RP; Carn VM; Black DN Vet Rec; 1994 Aug; 135(7):152-4. PubMed ID: 7880246 [TBL] [Abstract][Full Text] [Related]
55. Recombinant hemagglutinin protein of rinderpest virus expressed in insect cells induces cytotoxic T-cell responses in cattle. Sinnathamby G; Renukaradhya GJ; Rajasekhar M; Nayak R; Shaila MS Viral Immunol; 2001; 14(4):349-58. PubMed ID: 11792064 [TBL] [Abstract][Full Text] [Related]
56. [Small ruminant plague and its prevention in Senegal and in western Africa]. Bourdin P Rev Elev Med Vet Pays Trop; 1973; 26(4):71a-74a. PubMed ID: 4807991 [No Abstract] [Full Text] [Related]
57. [The use of the gene responsible for formation of hemorrhage as a phenotypic marker in creating hybrid variations of vaccinia virus]. Totmenin AV; Gashnikov PV; Shchelkunov SN; Sandakhchiev LS Dokl Akad Nauk SSSR; 1989; 305(5):1246-8. PubMed ID: 2752898 [No Abstract] [Full Text] [Related]
58. Safety of recombinant vaccinia vaccines. Baxby D Lancet; 1991 Apr; 337(8746):913. PubMed ID: 1672987 [No Abstract] [Full Text] [Related]
59. Poxvirus recombinant vaccines. Paoletti E Ann N Y Acad Sci; 1990; 590():309-25. PubMed ID: 2198832 [TBL] [Abstract][Full Text] [Related]
60. Recombinant vaccinia viruses as live virus vectors for vaccine antigens: memorandum from a WHO/USPHS/NIBSC meeting. Bull World Health Organ; 1985; 63(3):471-7. PubMed ID: 2994898 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]